Page last updated: 2024-09-05

tbc-11251 and catechol

tbc-11251 has been researched along with catechol in 1 studies

Compound Research Comparison

Studies
(tbc-11251)
Trials
(tbc-11251)
Recent Studies (post-2010)
(tbc-11251)
Studies
(catechol)
Trials
(catechol)
Recent Studies (post-2010) (catechol)
16732582,1755867

Protein Interaction Comparison

ProteinTaxonomytbc-11251 (IC50)catechol (IC50)
Carbonic anhydrase 1Homo sapiens (human)5.79
Carbonic anhydrase 2Homo sapiens (human)5.79
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)0.868
Carbonic anhydrase 6Homo sapiens (human)5.79
Glutaminyl-peptide cyclotransferaseHomo sapiens (human)5
Carbonic anhydrase 3Bos taurus (cattle)5.79

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erve, JC; Gauby, S; Maynard, JW; Quinn, KP; Svensson, MA; Tonn, G1

Other Studies

1 other study(ies) available for tbc-11251 and catechol

ArticleYear
Bioactivation of sitaxentan in liver microsomes, hepatocytes, and expressed human P450s with characterization of the glutathione conjugate by liquid chromatography tandem mass spectrometry.
    Chemical research in toxicology, 2013, Jun-17, Volume: 26, Issue:6

    Topics: Animals; Benzoquinones; Biotransformation; Catechols; Chromatography, Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Glutathione; Hepatocytes; Humans; Isoxazoles; Mice; Microsomes, Liver; Quantum Theory; Rats; Tandem Mass Spectrometry; Thiophenes

2013